Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
2.270
-0.020 (-0.87%)
Nov 5, 2024, 1:18 PM EST - Market open
Nuvation Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 760 | 331 | 419 | 1,851 | 210 | - | |
| Market Cap Growth | 83.25% | -21.16% | -77.35% | 779.62% | - | - | |
| Enterprise Value | 479 | -284 | -250 | 1,059 | 256 | - | |
| Last Close Price | 2.29 | 1.51 | 1.92 | 8.50 | 11.70 | - | |
| PE Ratio | - | -4.36 | -3.99 | -19.32 | -27.39 | - | |
| PB Ratio | 2.21 | 0.55 | 0.64 | 2.48 | 0.98 | - | |
| P/FCF Ratio | -8.56 | -4.86 | -4.35 | -27.04 | -5.74 | - | |
| P/OCF Ratio | -8.57 | -4.86 | -4.36 | -27.15 | -5.76 | - | |
| EV/EBITDA Ratio | -0.24 | 2.85 | 2.09 | -11.86 | -5.88 | - | |
| EV/EBIT Ratio | -0.24 | 2.85 | 2.09 | -11.83 | -5.87 | - | |
| EV/FCF Ratio | -1.52 | 4.18 | 2.59 | -15.47 | -6.97 | - | |
| Debt / Equity Ratio | 0.03 | 0.01 | 0.01 | 0.00 | - | - | |
| Debt / FCF Ratio | -0.17 | -0.06 | -0.04 | -0.04 | - | - | |
| Quick Ratio | 11.37 | 44.00 | 50.41 | 45.40 | 33.10 | 37.36 | |
| Current Ratio | 11.49 | 44.11 | 50.70 | 45.62 | 33.69 | 37.42 | |
| Return on Equity (ROE) | -88.30% | -12.03% | -14.87% | -18.07% | -25.03% | -57.35% | |
| Return on Assets (ROA) | -54.38% | -9.65% | -10.33% | -11.21% | -15.88% | -33.13% | |
| Return on Capital (ROIC) | -57.20% | -9.84% | -10.63% | -11.61% | -16.36% | -34.12% | |
| Earnings Yield | -66.62% | -22.93% | -24.85% | -4.69% | -19.79% | - | |
| FCF Yield | -10.99% | -20.59% | -23.01% | -3.70% | -17.43% | - | |
| Buyback Yield / Dilution | -3.12% | -1.00% | -9.52% | -102.90% | 52.81% | -155.19% | |
| Total Shareholder Return | -3.12% | -1.00% | -9.52% | -102.90% | 52.81% | -155.19% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.